story of the week
Stereotactic Ablative Body Radiotherapy for Bone Only Oligometastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Stereotactic Ablative Body Radiotherapy (SABR) for Bone Only Oligometastatic Breast Cancer: A Prospective Clinical Trial
Breast 2019 Nov 06;49(xx)55-62, S DavidFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.